SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AFFYMETRIX (AFFX)
AFFX 14.010.0%Apr 1 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: nigel bates4/10/2006 8:46:28 AM
   of 1728
 
Perlegen Sciences files for $115 million IPO
Mon Apr 10, 2006 6:43 AM ET

WASHINGTON, April 10 (Reuters) - Biopharmaceutical firm Perlegen Sciences Inc. on Monday said it was planning an initial public offering of as much as $115 million in common stock.

In a preliminary offering document filed with the U.S. Securities and Exchange Commission, the company did not set terms of the IPO, which will be underwritten by Lehman Brothers, Deutsche Bank Securities, Piper Jaffray and Allen & Company LLC.

Perlegen is seeking a Nasdaq listing under the symbol "PERL."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext